Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death Differ. 2023 May;30(5):1097-1154. doi: 10.1038/s41418-023-01153-w. Epub 2023 Apr 26.PMID: 37100955 

Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy. Ann Oncol. 2023 Mar;34(3):300-314. doi: 10.1016/j.annonc.2022.11.008. Epub 2022 Dec 6.PMID: 36494005 

tRNA-derived fragments are altered in diabetes. Diabet Med. 2023 Nov 7:e15258. doi: 10.1111/dme.15258. Online ahead of print.PMID: 37935454

Ketone body β-hydroxybutyrate (BHB) preserves mitochondrial bioenergetics. Sci Rep. 2023 Nov 11;13(1):19664. doi: 10.1038/s41598-023-46776-8.PMID: 37952048 

Chlorpromazine affects autophagy in association with altered Rag GTPase-mTORC1-TFEB signaling.

Front Cell Dev Biol. 2023 Sep 8:11:1266198. doi: 10.3389/fcell.2023.1266198. eCollection 2023

Functional expression of the ATP-gated P2X7 receptor in human iPSC-derived astrocytes.

Purinergic Signal. 2023 Jul 15. doi: 10.1007/s11302-023-09957-8. Online ahead of print.

Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death.

Nat Commun.  2023 Apr 14;14(1):2132. doi: 10.1038/s41467-023-37652-0.

Corrigendum: Mucinous adenocarcinoma of the rectum: a whole genome sequencing study.

Front Oncol. 2023 Jun 28;13:1229013. doi: 10.3389/fonc.2023.1229013. eCollection 2023.PMID: 37456242 

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer.

Mol Cancer Ther. 2023 Jan 3;22(1):135-149. doi: 10.1158/1535-7163.MCT-22-0301.PMID: 36279564

Comparative analysis of deeply phenotyped GBM cohorts of ‘short-term’ and ‘long-term’ survivors.

J Neurooncol. 2023 Jun;163(2):327-338. doi: 10.1007/s11060-023-04341-3. Epub 2023 May 26.PMID: 37237151

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers. Br J Cancer. 2023 Oct;129(8):1327-1338. doi: 10.1038/s41416-023-02402-y. Epub 2023 Aug 24.PMID: 37620410

Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells. Int J Mol Sci. 2023 Oct 27;24(21):15678. doi: 10.3390/ijms242115678.PMID: 37958662

Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome. J Mol Med (Berl). 2023 Jul;101(7):829-841. doi: 10.1007/s00109-023-02324-5. Epub 2023 May 12.PMID: 37171483 

Integrated analysis of transcriptomic and proteomic alterations in mouse models of ALS/FTD identify early metabolic adaptions with similarities to mitochondrial dysfunction disorders. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Oct 1:1-15. doi: 10.1080/21678421.2023.2261979.


Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer. Cell Oncol (Dordr). 2023 Nov 7. doi: 10.1007/s13402-023-00882-x. Online ahead of print.PMID: 37934338

Quantification of substoichiometric modification reveals global tsRNA hypomodification, preferences for angiogenin-mediated tRNA cleavage, and idiosyncratic epitranscriptomes of human neuronal cell-lines. Comput Struct Biotechnol J. 2022 Dec 19;21:401-417. doi: 10.1016/j.csbj.2022.12.020. eCollection 2023.PMID: 36618980 

Multiplexed Immunofluorescence Imaging Reveals an Immune-Rich Tumor Microenvironment in Mucinous Rectal Cancer Characterized by Increased Lymphocyte Infiltration and Enhanced Programmed Cell Death Protein 1 Expression. Dis Colon Rectum. 2023 Jul 1;66(7):914-922. doi: 10.1097/DCR.0000000000002624. Epub 2022 Nov 17.PMID: 36525395